Search

Attorney Jonathan Havens outlines what stood out for him most after reviewing the 252-page document released by the U.S. Department of Health & Human Services.

“[I]ndustry can move a lot quicker than Washington can. That’s always been the case. But it would be good if there was more clarity from Congress on a lot of these [hemp-related] issues. And, unfortunately, until you have a debated and negotiated Farm Bill, [the 2018 version is] just going to carry...

In a Bloomberg article titled, “Cannabis Industry Enjoys a Rare Moment of Progress,” Partner Zachary Kobrin discussed the implications of last week’s news that the U.S. Department of Health and Human Services is recommending looser restrictions for cannabis producers. Kobrin, who is based in Fort...

In a recent letter to the Drug Enforcement Administration (DEA), the Department of Health and Human Services (HHS) recommended that cannabis be reclassified as a Schedule III drug under the Controlled Substances Act. The DEA will conduct its own review of HHS’s findings before officially determining...

“When Congress removed hemp from the list of controlled substances and established a 0.3% limit on Delta-9 THC via the Agricultural Improvement Act of 2018, also known as the 2018 Farm Bill, it resulted in two somewhat unexpected product categories. The first was hemp-derived products, such as...